Meningitis A Vaccine Helping African Nations Pursue Disease’s Elimination
PATH Blog: Celebrating in Africa: the end of the reign of meningitis
Steve Davis, president and CEO of PATH, discusses progress against meningitis A in Africa, saying the bacterial infection has been nearly eliminated with the development and widespread use of the MenAfriVac vaccine (2/22).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.